RENALYTIX PLC's ticker is RNLX and the CUSIP is 75973T101. A total of 28 filers reported holding RENALYTIX PLC in Q3 2023. The put-call ratio across all filers is 4.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $957,504 | -42.0% | 598,440 | +5.9% | 0.01% | -54.5% |
| Q2 2023 | $1,649,800 | +36.3% | 565,000 | +13.0% | 0.01% | -8.3% |
| Q1 2023 | $1,210,000 | +7.8% | 500,000 | -16.7% | 0.01% | -40.0% |
| Q4 2022 | $1,122,000 | +22.2% | 600,000 | -16.3% | 0.02% | +100.0% |
| Q3 2022 | $918,000 | +49.8% | 716,824 | +186.7% | 0.01% | +42.9% |
| Q2 2022 | $613,000 | -60.6% | 250,000 | +11.1% | 0.01% | -63.2% |
| Q1 2022 | $1,557,000 | -40.0% | 225,000 | +37.9% | 0.02% | -32.1% |
| Q4 2021 | $2,595,000 | -14.4% | 163,200 | +7.9% | 0.03% | -9.7% |
| Q3 2021 | $3,033,000 | -1.7% | 151,262 | +51.3% | 0.03% | +24.0% |
| Q2 2021 | $3,086,000 | +2.4% | 100,000 | -14.9% | 0.02% | -13.8% |
| Q1 2021 | $3,015,000 | +22.8% | 117,500 | -23.5% | 0.03% | -3.3% |
| Q4 2020 | $2,456,000 | +12.2% | 153,500 | -14.5% | 0.03% | +7.1% |
| Q3 2020 | $2,188,000 | – | 179,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parian Global Management LP | 833,489 | $21,387,000 | 9.78% |
| Asymmetry Capital Management, L.P. | 160,969 | $4,130,000 | 2.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 134,555 | $3,453,000 | 1.88% |
| SCHOLTZ & COMPANY, LLC | 85,045 | $2,182,000 | 0.83% |
| Parian Global Management LP | 60,000 | $1,540,000 | 0.70% |
| GILDER GAGNON HOWE & CO LLC | 3,021,317 | $77,527,000 | 0.42% |
| Manatuck Hill Partners, LLC | 43,000 | $1,103,000 | 0.37% |
| Soleus Capital Management, L.P. | 80,000 | $2,053,000 | 0.37% |
| GOFEN & GLOSSBERG LLC /IL/ | 154,624 | $3,968,000 | 0.10% |
| Atom Investors LP | 18,335 | $470,000 | 0.08% |